• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

    4/26/24 8:18:32 AM ET
    $ACON
    $BYD
    $CSSE
    $DXCM
    Medical Specialities
    Health Care
    Hotels/Resorts
    Consumer Discretionary
    Get the next $ACON alert in real time by email

    Shares of Alphabet Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) rose sharply in today's pre-market trading the company posted upbeat results for its first quarter.

    Google parent Alphabet said its first-quarter revenue increased 15% year-over-year to $80.539 billion, beating the consensus estimate of $78.594 billion. The company reported quarterly earnings of $1.89 per share, beating analyst estimates of $1.51 per share, according to data from Benzinga Pro.

    Alphabet's board authorized an additional share repurchase program of up to $70 billion and also announced its first-ever quarterly dividend.

    Alphabet shares jumped 11.9% to $174.58 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Tevogen Bio Holdings Inc. (NASDAQ:TVGN) shares gained 64.7% to $1.40 in pre-market trading after falling over 43% on Thursday.
    • Pineapple Energy Inc. (NASDAQ:PEGY) gained 40.5% to $0.0729 in pre-market trading.
    • Freight Technologies, Inc. (NASDAQ:FRGT) climbed 32.4% to $1.21 in pre-market trading after gaining 5% on Thursday.
    • Snap Inc. (NYSE:SNAP) gained 24.2% to $14.16 in pre-market trading after the company reported better-than-expected first-quarter financial results and issued second-quarter revenue guidance above estimates. Also, the company reported a year-over-year increase in quarterly daily active users.
    • Earlyworks Co., Ltd (NASDAQ:ELWS) rose 20.7% to $0.88 in today's pre-market trading after gaining 19% on Thursday.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) shares gained 20.1% to $0.1898 in pre-market trading after gaining 15% on Thursday.
    • NewGenIvf Group Limited (NASDAQ:NIVF) shares gained 14.6% to $1.49 in pre-market trading after dipping 16% on Thursday.
    • ResMed Inc. (NYSE:RMD) shares rose 11.5% to $204.50 in pre-market trading after the company reported better-than-expected third-quarter financial results.
    • Skechers U.S.A., Inc. (NYSE:SKX) shares gained 11% to $65.30 in pre-market trading after the company reported better-than-expected first-quarter financial results.

    Losers

    • Aclarion, Inc. (NASDAQ:ACON) fell 19.5% to $0.3161 in pre-market trading. Aclarion shares jumped 36% on Thursday after the company announced that its Nociscan solution will be used in the upcoming LIFEHAB trial evaluating the diagnosis and treatment of chronic low back pain.
    • Vincerx Pharma, Inc. (NASDAQ:VINC) shares declined 16.4% to $0.75 in pre-market trading after the company announced pricing of underwritten public offering of common stock and warrants.
    • SCWorx Corp. (NASDAQ:WORX) fell 16.3% to $2.31 pre-market trading after surging 36% on Thursday.
    • Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) fell 15.4% to $2.05 in pre-market trading. Processa Pharmaceuticals shares jumped 50% on Thursday after HC Wainwright & Co initiated coverage on the stock with a Buy rating and announced an $8 price target.
    • Chicken Soup for the Soul Entertainment, Inc. (NASDAQ:CSSE) fell 13.9% to $0.2238 pre-market trading after dipping 39% on Thursday. Chicken Soup For The Soul Entertainment received delinquency letter from the Nasdaq.
    • Northann Corp. (NYSE:NCL) shares fell 13.6% to $0.4015 in pre-market trading after dipping 12% on Thursday.
    • Boyd Gaming Corporation (NYSE:BYD) shares declined 12.6% to $55.00 in pre-market trading after the company reported worse-than-expected first-quarter adjusted EPS results.
    • Intel Corporation (NASDAQ:INTC) shares fell 7.2% to $32.57 in pre-market trading after the company reported worse-than-expected first-quarter sales results and issued EPS guidance below estimates.
    • Hertz Global Holdings, Inc. (NASDAQ:HTZ) shares fell 5.8% to $4.41 in pre-market trading after dipping 19% on Thursday.
    • DexCom, Inc. (NASDAQ:DXCM) shares declined 5.3% to $130.70 in pre-market trading after the company reported first-quarter financial results.

    Now Read This: Microsoft, Alphabet And 3 Stocks To Watch Heading Into Friday

    Get the next $ACON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACON
    $BYD
    $CSSE
    $DXCM

    CompanyDatePrice TargetRatingAnalyst
    Tevogen Bio Holdings Inc.
    $TVGN
    3/4/2026Buy → Hold
    D. Boral Capital
    Alphabet Inc.
    $GOOGL
    2/23/2026$387.00Equal Weight → Overweight
    Wells Fargo
    Intel Corporation
    $INTC
    2/13/2026$45.00Neutral
    DA Davidson
    Snap Inc.
    $SNAP
    2/10/2026$7.30Neutral → Buy
    Arete
    Snap Inc.
    $SNAP
    2/6/2026$5.50Sell → Hold
    Stifel
    Alphabet Inc.
    $GOOG
    2/5/2026$400.00 → $420.00Buy
    Pivotal Research Group
    Snap Inc.
    $SNAP
    2/5/2026$10.00Neutral → Buy
    BofA Securities
    Alphabet Inc.
    $GOOGL
    1/26/2026$330.00 → $360.00Overweight
    KeyBanc Capital Markets
    More analyst ratings

    $ACON
    $BYD
    $CSSE
    $DXCM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CFO Zinsner David bought $249,985 worth of shares (5,882 units at $42.50), increasing direct ownership by 2% to 247,392 units (SEC Form 4)

    4 - INTEL CORP (0000050863) (Issuer)

    1/27/26 4:28:29 PM ET
    $INTC
    Semiconductors
    Technology

    Chief Executive Officer Ness Brent bought $62 worth of shares (10 units at $6.20), increasing direct ownership by 1,000% to 11 units (SEC Form 4)

    4 - Aclarion, Inc. (0001635077) (Issuer)

    12/1/25 5:00:02 PM ET
    $ACON
    Medical Specialities
    Health Care

    President & COO Leach Jacob Steven bought $1,001,702 worth of shares (18,200 units at $55.04), increasing direct ownership by 6% to 331,697 units (SEC Form 4)

    4 - DEXCOM INC (0001093557) (Issuer)

    11/10/25 7:13:08 PM ET
    $DXCM
    Medical/Dental Instruments
    Health Care

    $ACON
    $BYD
    $CSSE
    $DXCM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Freudenthaler Paul D

    3 - Freight Technologies, Inc. (0001687542) (Issuer)

    3/19/26 6:43:56 AM ET
    $FRGT
    Professional Services
    Consumer Discretionary

    SEC Form 3 filed by new insider Gonzalez Leon Jose Andres

    3 - Freight Technologies, Inc. (0001687542) (Issuer)

    3/19/26 6:40:35 AM ET
    $FRGT
    Professional Services
    Consumer Discretionary

    SEC Form 3 filed by new insider Selgas Javier

    3 - Freight Technologies, Inc. (0001687542) (Issuer)

    3/19/26 6:38:04 AM ET
    $FRGT
    Professional Services
    Consumer Discretionary

    $ACON
    $BYD
    $CSSE
    $DXCM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Freight Technologies Releases Pro Forma Financial Statements for JAK Solar Acquisition

    HOUSTON, March 19, 2026 (GLOBE NEWSWIRE) -- Freight Technologies, Inc. (NASDAQ:FRGT, "Fr8Tech" or the "Company")), a logistics management innovation company offering a diverse portfolio of technology-driven solutions, today released the unaudited pro forma financial statements related to its acquisition of JAK Solar Loans 1 Limited ("JAK Solar"), which was completed on December 31, 2025. The unaudited pro forma condensed combined financial information includes a balance sheet as of September 30, 2025 and statements of operations for the nine months ended September 30, 2025 and the year ended December 31, 2024. The pro forma financial statements have been prepared in accordance with Articl

    3/19/26 5:50:45 PM ET
    $FRGT
    Professional Services
    Consumer Discretionary

    Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan

    BROOMFIELD, Colo., March 19, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc. (NASDAQ:ACON, ACONW)) ("Aclarion" or the "Company") today announced that its Board of Directors (the "Board") has unanimously adopted a limited duration stockholder rights plan (the "Rights Plan"). The Rights Plan is effective immediately and expires in one year. The Rights Plan is intended to enable all stockholders to realize the long-term value of their investment in Aclarion. The Rights Plan is also intended to reduce the likelihood that any person or group gains control of the Company without paying all stockholders an appropriate control premium. The Rights Plan will help to ensure the Board has sufficient time to

    3/19/26 9:25:40 AM ET
    $ACON
    Medical Specialities
    Health Care

    Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts

    Pursuing reimbursement coverage from one or more regional insurance providers in the United States as an important step toward broader payer adoption Initial CLARITY trial readout in Q4 2026 Strong Balance Sheet with Cash Runway into 2028 BROOMFIELD, Colo., March 19, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today the publication of a Shareholder Letter from Chief Executive Officer Brent Ness providing an update on the company's

    3/19/26 6:00:00 AM ET
    $ACON
    Medical Specialities
    Health Care

    $ACON
    $BYD
    $CSSE
    $DXCM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    March 22, 2024 - FDA Roundup: March 22, 2024

    For Immediate Release: March 22, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]).  Pemgarda is

    3/22/24 5:02:42 PM ET
    $SNAP
    $SRAX
    Computer Software: Programming Data Processing
    Technology
    Advertising
    Consumer Discretionary

    November 9, 2023 - FDA Approves First Treatment for Patients with Rare Inherited Blood Clotting Disorder

    For Immediate Release: November 09, 2023 Today, the U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), a rare and life-threatening blood clotting disorder. “The FDA remains

    11/9/23 2:30:20 PM ET
    $SRAX
    $SNAP
    Advertising
    Consumer Discretionary
    Computer Software: Programming Data Processing
    Technology

    $ACON
    $BYD
    $CSSE
    $DXCM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tevogen Bio downgraded by D. Boral Capital

    D. Boral Capital downgraded Tevogen Bio from Buy to Hold

    3/4/26 9:36:27 AM ET
    $TVGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Alphabet A upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Alphabet A from Equal Weight to Overweight and set a new price target of $387.00

    2/23/26 8:28:41 AM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    DA Davidson initiated coverage on Intel with a new price target

    DA Davidson initiated coverage of Intel with a rating of Neutral and set a new price target of $45.00

    2/13/26 8:31:53 AM ET
    $INTC
    Semiconductors
    Technology

    $ACON
    $BYD
    $CSSE
    $DXCM
    SEC Filings

    View All

    SEC Form DEFA14A filed by Boyd Gaming Corporation

    DEFA14A - BOYD GAMING CORP (0000906553) (Filer)

    3/20/26 8:32:19 AM ET
    $BYD
    Hotels/Resorts
    Consumer Discretionary

    SEC Form DEF 14A filed by Boyd Gaming Corporation

    DEF 14A - BOYD GAMING CORP (0000906553) (Filer)

    3/20/26 8:30:43 AM ET
    $BYD
    Hotels/Resorts
    Consumer Discretionary

    SEC Form 6-K filed by Freight Technologies Inc.

    6-K - Freight Technologies, Inc. (0001687542) (Filer)

    3/19/26 5:28:08 PM ET
    $FRGT
    Professional Services
    Consumer Discretionary

    $ACON
    $BYD
    $CSSE
    $DXCM
    Leadership Updates

    Live Leadership Updates

    View All

    Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform

    WARREN, N.J., March 11, 2026 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN) today issued a statement from Founder and CEO Dr. Ryan Saadi regarding the company's progress in developing TVGN 489 for Long COVID, timed with International Long COVID Awareness Month. Following the appointment of a new leadership team on March 9, 2026, Tevogen is accelerating its "Biotech" and "Digital Health" verticals to move TVGN 489 into its next clinical phase. The company is currently evaluating the acquisition of Sciometrix and its Clinicus platform to provide real-world monitoring for Long COVID patients. Tevogen continues to prioritize the development of TVGN 489,

    3/11/26 3:15:00 PM ET
    $TVGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Tevogen Names Leadership Team to Execute Diversified Growth Strategy

    WARREN, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN) today announced the appointment of interim leaders across its core business verticals to execute the first phase of its diversified growth strategy. In this first phase, Tevogen is evaluating strategic opportunities that, if completed, are expected to operate as subsidiaries of the Company and could collectively generate annual revenues exceeding $50 million. The Company expects these transactions to close by the second quarter of 2026, subject to customary due diligence and definitive agreements. Leadership Designations: Digital Health: Arpita Patel and Wojtek StobinskiGene

    3/9/26 7:45:00 AM ET
    $TVGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Dexcom Appoints Rick Osterloh to Board of Directors

    DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Rick Osterloh to its Board of Directors, effective February 26, 2026. Mr. Osterloh is a highly accomplished technology executive with more than 20 years of leadership experience across consumer hardware, platform strategy and large-scale product operations. He currently serves as Senior Vice President, Platforms & Devices at Google, where he leads a unified group spanning the company's portfolio of advanced consumer technologies. This includes Android, Google Play, Chrome, and Google's Devices and Services Portfolio—Pixel phones, Google Nest smart home devices, and Fitbit wearables. Und

    2/26/26 4:15:00 PM ET
    $DXCM
    Medical/Dental Instruments
    Health Care

    $ACON
    $BYD
    $CSSE
    $DXCM
    Financials

    Live finance-specific insights

    View All

    Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan

    BROOMFIELD, Colo., March 19, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc. (NASDAQ:ACON, ACONW)) ("Aclarion" or the "Company") today announced that its Board of Directors (the "Board") has unanimously adopted a limited duration stockholder rights plan (the "Rights Plan"). The Rights Plan is effective immediately and expires in one year. The Rights Plan is intended to enable all stockholders to realize the long-term value of their investment in Aclarion. The Rights Plan is also intended to reduce the likelihood that any person or group gains control of the Company without paying all stockholders an appropriate control premium. The Rights Plan will help to ensure the Board has sufficient time to

    3/19/26 9:25:40 AM ET
    $ACON
    Medical Specialities
    Health Care

    Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization

    Lead investor confirmed his intention to maintain his current shareholdings.Company does not anticipate using more than 1% of our authorized shares, including placement through the ATM, over the next 12 months or until the company becomes cash-flow positive.Approximately only one-fifth of total shares outstanding are in the tradable float when accounting for Tevogen's lead investor, directors and named executive officers.Company prioritizing long-term stock-based incentive program aligned with company milestones.Board of Directors continues to evaluate the potential declaration of a one-time special cash dividend to shareholders.Company continues to evaluate acquisitions that could generate

    3/13/26 2:45:00 PM ET
    $TVGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    BOYD GAMING INCREASES QUARTERLY DIVIDEND TO $0.20 PER SHARE

    LAS VEGAS, Feb. 19, 2026 /PRNewswire/ -- Boyd Gaming Corporation (NYSE:BYD) announced that its Board of Directors has increased the Company's quarterly dividend to $0.20 per share, up from the prior quarterly dividend of $0.18 per share. The dividend is payable April 15, 2026, to shareholders of record at the close of business on March 16, 2026. About Boyd GamingFounded in 1975, Boyd Gaming Corporation (NYSE:BYD) is a leading geographically diversified operator of 27 gaming entertainment properties in 11 states. The Company also manages a tribal casino in northern California, an

    2/19/26 4:45:00 PM ET
    $BYD
    Hotels/Resorts
    Consumer Discretionary

    $ACON
    $BYD
    $CSSE
    $DXCM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by SCWorx Corp.

    SC 13G - SCWorx Corp. (0001674227) (Subject)

    12/5/24 7:17:43 AM ET
    $WORX
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SEC Form SC 13G filed by SCWorx Corp.

    SC 13G - SCWorx Corp. (0001674227) (Subject)

    11/26/24 5:02:01 PM ET
    $WORX
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Tevogen Bio Holdings Inc.

    SC 13G/A - Tevogen Bio Holdings Inc. (0001860871) (Subject)

    11/14/24 5:29:01 PM ET
    $TVGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care